Peripheral blood myeloperoxidase activity increases during hemodialysis.

作者信息

Rutgers Abraham, Heeringa Peter, Kooman Jeroen P, van der Sande Frank M, Cohen Travaert Jan Willem

出版信息

Kidney Int. 2003 Aug;64(2):760. doi: 10.1046/j.1523-1755.2003.00139.x.

DOI:10.1046/j.1523-1755.2003.00139.x

PMID:12846778

Abstract

摘要

相似文献

Peripheral blood myeloperoxidase activity increases during hemodialysis.

Kidney Int. 2003 Aug;64(2):760. doi: 10.1046/j.1523-1755.2003.00139.x.

Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.

Nephrol Dial Transplant. 2006 Feb;21(2):546; author reply 546. doi: 10.1093/ndt/gfi222. Epub 2005 Oct 25.

[The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].

Ann Acad Med Stetin. 2004;50(1):41-52.

Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.

Hemodial Int. 2010 Jul;14(3):308-15. doi: 10.1111/j.1542-4758.2010.00455.x. Epub 2010 Jun 28.

Fibrinogen in hemodialysis: the worst of both worlds?

Kidney Int. 2003 Jan;63(1):379-80. doi: 10.1046/j.1523-1755.2003.00748.x.

Evaluation of oxidative and nitrosative stress in hemodialysis patients.

Minerva Med. 2010 Oct;101(5):305-10.

Changes in the composition of carnitines in hemodialysis patients.

Kidney Int. 2005 Sep;68(3):1368; author reply 1368-9. doi: 10.1111/j.1523-1755.2005.00536_1.x.

Busulfan clearance in renal failure and hemodialysis.

Bone Marrow Transplant. 2000 Jan;25(2):201-3. doi: 10.1038/sj.bmt.1702112.

[Effect of hemodialysis on intestinal iron absorption in chronic kidney insufficiency].

Verh Dtsch Ges Inn Med. 1974;80:681-4.

[Oxidative stress in patients on regular hemodialysis and peritoneal dialysis].

Vnitr Lek. 2012 Jun;58(6):466-72.

引用本文的文献

Head-to-Head Comparison of Oxidative Stress Biomarkers for All-Cause Mortality in Hemodialysis Patients.

Antioxidants (Basel). 2022 Oct 2;11(10):1975. doi: 10.3390/antiox11101975.

Association between MPO-463G > A polymorphism and chronic kidney disease: a meta-analysis.

Ren Fail. 2018 Nov;40(1):541-546. doi: 10.1080/0886022X.2018.1499529.

Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins.

Toxins (Basel). 2016 Dec 16;8(12):376. doi: 10.3390/toxins8120376.

Role of Myeloperoxidase in Patients with Chronic Kidney Disease.

Oxid Med Cell Longev. 2016;2016:1069743. doi: 10.1155/2016/1069743. Epub 2016 Apr 3.

Effect of Hemodialysis on Plasma Myeloperoxidase Activity in End Stage Renal Disease Patients.

Indian J Clin Biochem. 2012 Jul;27(3):253-8. doi: 10.1007/s12291-012-0194-y. Epub 2012 Mar 24.

Effects of uremic solutes on reactive oxygen species in vitro model systems as a possibility of support the renal function management.

BMC Nephrol. 2015 Apr 11;16:50. doi: 10.1186/s12882-015-0029-1.

Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100.

J Lipid Res. 2014 Apr;55(4):747-57. doi: 10.1194/jlr.M047449. Epub 2014 Feb 17.

Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.

Mediators Inflamm. 2013;2013:971579. doi: 10.1155/2013/971579. Epub 2013 Jul 24.

Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins.

Clin Exp Immunol. 2007 Aug;149(2):257-64. doi: 10.1111/j.1365-2249.2007.03420.x. Epub 2007 May 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验